Quality of life and economic evaluation in SLE clinical trials

被引：29

作者：

Gordon, C

Clarke, AE

机构：

[1] McGill Univ, Div Clin Epidemiol, Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada

[2] McGill Univ, Div Allergy Clin Immunol, Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada

[3] Univ Birmingham, Dept Rheumatol, Div Immun & Infect, Birmingham, W Midlands, England

来源：

LUPUS | 1999年 / 8卷 / 08期

关键词：

systemic lupus erythematosus; quality of life; health status; direct medical costs; indirect costs;

D O I：

10.1191/096120399680411344

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Outcome in SLE patients should include assessment of disease activity and chronic damage and also measurement of health-related quality of life and the economic impact of the disease. This paper reviews the methods available for doing this and the results of existing studies in SLE patients.

引用

页码：645 / 654

页数：10

共 86 条

[71]

Strand V, 1999, J RHEUMATOL, V26, P490

[72]

SUTCLIFFE N, 1999, IN PRESS J RHEUMATOL

[73]

Taylor J, 1998, ARTHRITIS RHEUM-US, V41, pS332

[74]

Thomas E, 1998, BRIT J RHEUMATOL, V37, P1069

[75]

Thumboo J, 1999, J RHEUMATOL, V26, P97

[76] Measures of disease activity and damage in SLE [J].

Urowitz, MB ;

Gladman, DD .

BAILLIERES CLINICAL RHEUMATOLOGY, 1998, 12 (03) :405-413

[77]

UTSET TO, 1994, J RHEUMATOL, V21, P2039

[78]

Valladolid GR, 1998, REV CLIN ESP, V198, P61

[79]

van Jaarsveld CHM, 1998, BRIT J RHEUMATOL, V37, P837

[80] Recommendations of the panel on cost-effectiveness in health and medicine [J].

Weinstein, MC ;

Siegel, JE ;

Gold, MR ;

Kamlet, MS ;

Russell, LB .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (15) :1253-1258

← 1 2 3 4 5 6 7 8 9 →